Chemotherapy is indicated for acute lymphocytic leukemia and can be divided in several phases: induction chemotherapy, consolidation therapy, CNS prophylaxis and maintenance treatments with chemotherapeutic drugs such as prednisone plus Vincristine plus cyclophosphamide plus doxorubicin or methotrexate plus 6-MP. Radiation therapy is used on painful bony areas in severe disease or as part of the preparations for a bone marrow transplant. Drugs approved for acute<unk>  leukemia include: Methotrexate, nelarabine, blinatumomab, cyclophosphamide, clofarabine, cytarabine, dasatinib, doxorubicin hydrochloride, mercaptopurine, pegaspargase, prednisone. A therapy that was recently approved by the Food and Drug Administration is chimeric antigen receptor T (CAR-T) cell therapy in the form of tisagenlecleucel, which is used in patients with B cell acute<unk>  leukemia.
Acute lymphoblastic leukemia medical therapy
Acute myeloid leukemia medical therapy
Chronic myelogenous leukemia medical therapy
Chronic lymphocytic leukemia medical therapy
Acute promyelocytic leukemia medical therapy
Hairy cell leukemia medical therapy
Myeloproliferative neoplasm medical therapy
Adult T-cell leukemia medical therapy